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In the neural circuits that comprise the crustacean stomatogas- 
tric nervous system (STNS), synaptically delivered neurotrans- 
mitters and circulating neurohormones elicit a wide range of 
rhythmic motor ouputs. However, functional roles for second 
messengers in this system are poorly understood. Here we 
demonstrate two different signaling pathways that control the 
synthesis of 3’,5’-cGMP in the crab STNS. One pathway is 
activated by nitric oxide (NO) and is mediated by a cytoplasmic 
guanylate cyclase. A second pathway is stimulated by peptide- 
containing extracts from a crab neurohemal organ that activate 
a membrane-associated guanylate cyclase. Using whole- 
mount immunocytochemistry to localize individual cGMP- 
containing cells, we find that NO elevates intracellular cGMP in 
a small subset of STNS neurons. lmmunopositive cells are 
found predominantly in the stomatogastric ganglion, with a few 
additional cells located in the oesophageal and commissural 
ganglia. Crab tissues differ in their sensitivities to NO and to the 
peptide-containing extract. The NO-mediated pathway is ap- 
parently restricted to the nervous system, whereas the peptide- 
mediated pathway is present in every tissue tested. The results 
of these experiments demonstrate that multiple signaling path- 
ways involving cGMP are present in the STNS and suggest that 
this second messenger may help control the metabolic and 
physiological status of these motor circuits. 
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Many neurotransmitters and hormones modulate target cells by 
elevating intracellular concentrations of 3’,5’-cGMP (Goy, 1991; 
Waldman and Murad, 1987). Synthesis of cGMP is under the 
control of two broad classes of guanylate cyclase (Yuen and 
Garbers, 1992; Schmidt et al., 1993): a family of soluble enzymes, 
which can be stimulated by the inter- and intracellular messenger 
nitric oxide (NO), and a family of membrane-associated enzymes, 
which can be stimulated by peptide agonists. In the vertebrate 
CNS, cGMP plays an important role in diverse processes, includ- 
ing visual transduction (Stryer, 1986), olfaction (Breer and Shep- 
herd, 1993) and synaptic transmission (Arancio et al., 1995). 
In vertebrates, NO-activated cGMP has also been implicated in 
the regulation of the enteric nervous system, including control of 
peristaltic contractions and reflex responses throughout the gas- 
trointestinal tract (Rand and Li, 1995), modulation of synaptic 
efficacy (Baccari, 1994; Yuan et al., 1995), and shifting of pat- 
terned motor output from an active to a postprandial quiescent 
state (Rodriguez-Membrilla et al., 1995). Furthermore, a family of 
peptides (e.g., guanylin and uroguanylin) regulates intestinal ion 
transport by activating a membrane-associated guanylate cyclase 
(Wiegand et al. 1992; Ham et al., 1993). 
cGMP may also serve functional roles in olfaction, feeding, and 
digestion among invertebrates. For example, NO-mediated signaling 
pathways occur in the olfactory centers of insects (Miiller and Bicker, 
1994; Elphick et al., 1995) and terrestrial molluscs (Gelperin, 1994). 
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The buccal ganglia of snails contain neurons that are immunopositive 
for NO synthase (NOS) and motor patterns associated with feeding 
are elicited with exposure to NO (Moroz et al., 1993). Finally, the 
crustacean hyperglycemic peptides (CHHs), which act through a 
membrane guanylate cyclase (Goy, 1990), control glucose metabo- 
lism and energy storage in the hepatopancreas (Sedlmeier and 
Keller, 1981) and the secretion of digestive enzymes (Sedlmeier, 
1988). 
The stomatogastric nervous system (STNS) of decapod crusta- 
ceans is an important model for studying how patterned motor 
output is generated by ensembles of neurons. Furthermore, it is 
the main neuronal network controlling digestive function. Within 
the stomatogastric ganglion (STG), -30 neurons are loosely or- 
ganized into two central pattern-generating (CPG) circuits that 
coordinate the movements of the gastric mill and pylorus. The 
physiological properties of STG neurons have been studied inten- 
sively, as has their modulation by an array of synaptically delivered 
peptidergic and aminergic neurotransmitters (Harris-Warrick et 
al., 1992). Despite this, little is known about transmitter-activated 
second messenger pathways in this system. 
As a first step toward understanding how cGMP participates in the 
physiological organization of STNS networks, we used anti-cGMP 
radioimmunoassays (RIAs) and anti-cGMP immunocytochemistry 
(ICC) to investigate the effects of NO and crustacean europeptides 
on cGMP biosynthesis in the STNS. This approach permits a quan- 
titative analysis of overall increases in cGMP content in the SINS, 
and provides an anatomical map of specific populations of responsive 
cells. 
MATERIALS AND METHODS 
Animals and materials 
Adult male rock crabs (Cancer productus) were hand-collected from 
Puget Sound and maintained without food in seawater aquaria at 12°C. 
Animals were anesthetized by chilling on ice, and then the STNS (Fig. 1) 
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Figure 1. Schematic diagram of the crab STNS. The indicated abbrevia- 
tions are used throughout the text. 
was dissected as described by Mulloney and Selverston (1974). Briefly, the 
foregut was removed, cut ventrally, and pinned with the dorsal side up in 
a dish containing cold crab saline (440 mM NaCl, 11 mM KCl, 13 mM 
CaCl,, 26 mM MgCl,, and 10 mM HEPES, pH-adjusted to 7.4 with 
NaOH). The STNS, consisting of the STG, the oesophageal ganglion 
(OG), the paired commissural ganglia (CGs), and anterior nerves (son, 
ion, and stn), was isolated from the foregut and transferred to a 2 ml/well 
tissue culture dish (Nunclon). In a few experiments, the posterior nerves 
were also included. All other tissues were dissected in cold saline and 
transferred to glass vials. 
ICC 
Stimulation with NO donors. Nervous systems were stimulated for 15 min 
in vitro by replacing the bathing solution with crab saline containing the 
phosphodiesterase inhibitor isobutylmethylxanthine [0.5 mM I-methyl-3- 
isobutylxanthine (IBMX), Sigma, St. Louis, MO] and 10 mM sodium 
nitroprusside (SNP, Sigma), 1 mM 3-morpholino-sydnonimine (SIN-l, Bi- 
omol, Plymouth Meeting, PA), or 1 mM S-nitroso-N-acetylpenicillamine 
(SNAP, Biomol). SNAP was first dissolved in a small volume of dimeth- 
ylsulfoxide (DMSO; 1% final concentration). Each NO donor is maxi- 
mally active in rat cerebellar slices at these concentrations (Southam and 
Garthwaite, 1991). Additional nervous systems were treated with NO 
donors alone, IBMX alone, or were left untreated. 
Stimulation with peptide extract. Individual sinus glands were isolated 
from eyestalks and homogenized in saline containing 0.5 mM IBMX. 
Twelve sinus glands were homogenized per ml saline. From this stock 
solution, peptide extract was applied in IBMX-containing saline to in vitro 
nervous systems for 90 min (the longest time interval at which the 
response is still linear) at a final concentration of 10 ~l/ml. 
cGMP immunostaining. The rabbit anti-cGMP polyclonal antibody 
used in this study has been described previously (De Vente et al., 1987). 
Free-floating nervous systems were fixed overnight at 4°C in 4% 
paraformaldehyde (Electron Microscopy Sciences, Ft. Washington, PA) 
in 0.1 M PBS. Tissues were washed in PBS containing 0.3% Triton X-100 
(PBST; Sigma) and incubated overnight with a rabbit anti-cGMP anti- 
serum (l:lOOO, donated by Dr. Jan De Vente, University of Limburg, The 
Netherlands). After a second wash series in PBST, STNSs were incubated 
overnight in a biotinylated goat anti-rabbit secondary antibody (1:lOOO; 
Vector Laboratories, Burlingame, CA), and cGMP-like immunoreactivity 
was visualized with an avidin-biotin-peroxidase complex (ABC Kit, Vec- 
tor) using 0.5 mg/ml diaminobenzidine (DAB) and 0.003-0.01% H,O, 
(Sigma). In some experiments, a peroxidase-conjugated goat anti-rabbit 
secondary antibody (1:300, Jackson Immunoresearch, West Grove, PA) 
was used, and the sites of antibody binding were visualized with DAB 
using the glucose oxidase technique (Watson and Burrows, 1981). The 
latter approach generally resulted in a lower background. Labeled ner- 
vous systems were arranged on poly-L-lysine-coated coverslips, dehy- 
drated in alcohol, cleared in xylene, and mounted in DPX Mountant 
(Fluka, Buchs, Switzerland) or Permount (Fisher, Pittsburgh, PA). 
Controls. The specificity of the anti-cGMP antibody for its antigen has 
been characterized in detail (De Vente et al., 1987). In this study, we 
preabsorbed the primary antiserum at room temperature for 1 hr in 
known concentrations of cGMP, CAMP, or GMP (Sigma), and subse- 
quently applied the preabsorbed antiserum to STNSs that had been 
stimulated with NO and IBMX. Tissues were also processed in the 
absence of primary antisera. 
RZAS 
A competitive binding assay (RIA) was used to measure the cGMP 
content of STNSs in each treatment group (Goy, 1990). Treatment 
groups and stimulus concentrations were identical to those for immuno- 
cytochemical experiments. Nervous systems were preincubated (12°C) for 
30 min in saline (containing IBMX where required), stimulated for 15 
min (NO donors) or 90 min (peptide extract), and homogenized in 6% 
trichloroacetic acid (TCA). Each homogenate was centrifuged, and the 
cGMP content (soluble fraction) was determined by RIA after ether 
extraction to eliminate TCA (Brooker et al., 1979). The antibody was 
obtained from Woods Assay (Portland, OR), and the [‘251]2’-o- 
monosuccinylguanosine 3’,5’cyclic monophosphate tyrosylmethylester 
trace was prepared according to standard procedures (Hunter and 
Greenwood, 1962). Values were corrected for protein content using a 
spectrophotometric dye-binding assay (Bio-Rad, Hercules, CA) based on 
the method by Bradford (1976). 
Guanylate cyclase assay 
We assayed cytosolic and membrane fractions of the STNS for guanylate 
cyclase activity following the procedure outlined by Goy (1990). In each 
experiment, STNSs (4 total) were dissected in cold saline and homoge- 
nized in 1.5 ml of buffer B (50 mM HEPES, 1 mM EDTA, and 0.1% 
bacitracin, pH 7.4). The homogenate was centrifuged for 1 hr at 100,000 
x g (4°C) and the upper two-thirds of the soluble fraction was retained. 
The remaining supernatant was discarded, and the membranes were 
washed by vortexing in buffer C (buffer B plus 100 mM KCl) and 
centrifuging for 1 hr at 100,000 X g. This step was repeated using buffer 
B instead of buffer C, and the final pellet was resuspended by homoge- 
nization in buffer B. Aliquots of both fractions were assayed for protein 
content (as above). 
Cyclase activity was assayed at 4, 10, and 20°C. Aliquots of each 
fraction were mixed with buffer A [50 mM HEPES, 8 mM MgCl,, 2 mM 
IBMX, 4 mM GTP, 60 mM phosphocreatine, 800 &ml creatine kinase 
(185 Uimg), and 1 mg/ml BSA, pH 7.41, to which we had added 10 mM 
SNP, 10 Fl/ml peptide extract, or an equivalent volume of buffer B. 
Cyclase activity was terminated at various times (15, 30, and 45 min) with 
6% TCA, and cGMP was measured by RIA after ether extraction. The 
rate of synthesis was determined as the slope of a straight line fit by linear 
regression to each time course. 
RESULTS 
NO donors activate cGMP synthesis in the STNS 
In the vertebrate nervous system, NOS enzymes generate NO 
from L-Arg. As a nonpolar gas, NO may then diffuse readily across 
cell membranes. Several compounds have been used to generate 
NO in the vicinity of potential neuronal targets (Southam and 
Garthwaite, 1991). Among these are SNP, SIN-l, and SNAP. We 
used all three of these donors (each with a different mechanism of 
NO release) to ensure that NO, and not an alternate breakdown 
product, was the stimulus responsible for elevating cGMP. To 
ascertain whether NO can stimulate cGMP metabolism in the 
STNS, we applied each of these donors in tandem with the 
phosphodiesterase inhibitor IBMX and measured cGMP levels 
















SNAP SNP SIN-1 IBMX saline 
IBhX IBhX IB+MX 
alone alone 
Figure 2. cGMP production in the STNS by NO donors. Each donor, 
applied with IBMX, elicited a significant increase in cGMP biosynthesis 
compared with treatment with IBMX alone. Data are the mean i SEM, 
and replicates are shown in parentheses. *p < 0.05; **p < 0.01; ***JJ < 
0.005 (Student’s t test). 
with an RIA (Fig. 2). Whereas IBMX alone produced a slight 
increase in cGMP content compared with basal evels, NO donors 
produced an additional lo-fold (SNP and SIN-l) to 20-fold 
(SNAP) increase in cGMP; this indicates that some population of 
cells in the STNS expresses a guanylate cyclase that can be 
activated by NO. 
Peptides extracted from sinus glands stimulate 
cGMP metabolism 
The eyestalk sinus gland of decapod crustaceans has long been 
recognized as a major neurohemal organ and a release site for 
members of the crustacean CHHs that have cGMP-stimulating 
effects on a range of peripheral tissues (Sedlmeier and Keller, 
1981; Goy et al., 1987, 1990; Keller, 1992). Two closely related 
forms of CHH have been identified (CHH-A and CHH-B; Tensen 
et al., 1991) and these appear to be the only two sinus gland 
peptides capable of influencing cGMP metabolism (M. Goy, un- 
published data). Although CHHs have been purified from some 
decapods, including the shore crab Carcinus maenas (Kegel et al., 
1989) the crayfish Orconectes (Kegel et al., 1991; Huberman et al., 
1993), and the lobster Homarus americanus (Chang et al., 1990; 
Pavloff and Goy, 1990; Tensen et al., 1991), they have not been 
purified from the crab used in the present study. The actions of 
CHHs are highly species-specific, arising from differences in 
amino acid sequence (Keller, 1992). For example, C. maenas 
CHH does not effect cGMP levels in H. americanus muscle when 
tested at concentrations sufficient to cause a saturating response 
in crab muscle (Goy et al., 1987). Therefore, we used extracts 
from C. productus sinus glands, a rich source of CHHs (Dircksen 
et al., 1988). Sinus gland extract was a potent activator of cGMP 
in the STNS, stimulating a 30-fold increase in cGMP levels com- 
pared with treatment with IBMX alone (Fig. 3). 
The STNS contains both a membrane and a cytosolic 
guanylate cyclase 
The fact that NO and the sinus gland extract both stimulate cGMP 
production in the STNS suggests that independent signaling path- 
ways may be involved. NO is known to activate a soluble guanylate 










Figure 3. cGMP production in the STNS by extract from the sinus gland. 
The extract stimulated a significant increase @ < 0.005, Student’s t test) in 
cGMP production compared with treatment with IBMX alone. Data are 
the mean 2 SEM, and replicates are shown in parentheses. 
CHH family target a membrane cyclase (Goy, 1990) in a manner 
that appears comparable with the actions of atria1 natriuretic 
peptide on its receptor in vertebrates (Chinkers et al., 1989). To 
explore whether these two cGMP-production pathways are ex- 
pressed in the STNS, we first investigated whether this tissue 
contains both a soluble and a membrane-associated enzyme (Fig. 
4). When membranes and cytosol were separated by high-speed 
centrifugation, both fractions exhibited comparable specific activ- 
ities of basal guanylate cyclase activity. We tested the relative 
proportions of cyclase activity across the range of temperatures 
experienced by these animals in their natural environment (4- 
20°C). Although both cytosolic and membrane-associated cyclases 
show marked temperature dependence, the ratio and absolute 
value of the two forms remain constant at all temperatures (Fig. 
U). Interestingly, in exoskeletal muscle (the only other crusta- 
cean tissue previously tested) the specific activity of the cytosolic 
cyclase is much lower than that of the membrane cyclase (Goy, 
1990) suggesting that the cytosolic enzyme may play a more 
important role in the STNS than it does in contractile tissues. 
When we tested the effect of peptide extract on cyclase activity, 
we found that, as expected, it nearly doubled the rate of cGMP 
synthesis by the membrane cyclase (Fig. 4B, open symbols) without 
any significant effect on the rate of synthesis by the cytoplasmic 
enzyme (Fig. 4C, open symbols). Also as expected, SNP stimulated 
the activity of the cytoplasmic cyclase more than threefold (Fig. 
4C, solid symbols) with no effect on the membrane-associated 
enzyme (Fig. 4B, solid symbols). Somewhat surprisingly, however, 
SNP only effectively stimulated the cytosolic enzyme at 4°C. We 
do not know the reason for the lack of responsiveness of the 
enzyme at higher temperatures, but we suspect hat one explana- 
tion is its unusual lability: storage of the cytosolic preparation for 
even a short period of time caused a complete loss of NO 
responsiveness at any temperature (data not shown). 
Cellular sites of cGMP synthesis in the STNS 
We used whole-mount anti-cGMP ICC to identify individual 
cGMP-synthesizing cells in the STNS. When NO donors were 
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F@re 4. Guanylate cyclase activities in the STNS. A, Basal cyclase 
activity in cytosolic and membrane fractions of the STNS as a function of 
temperature. Rates were determined as described in Materials and Meth- 
ods. B, C, Effects of NO and sinus gland extract on purified membrane and 
cytosolic fractions, respectively. Each value in B and C gives the stimulated 
rate compared with the appropriate control (basal) rate. Data are the 
mean i SEM for two to four experiments. 
tested in combination with IBMX, each increased cGMP immu- 
noreactivity in specific cells and processes in the STNS (Figs. 
5A-C, 6). The effect was the same regardless of NO donor. In the 
CG and OG (see Fig. 1 for anatomical definitions), the same 
subset of neurons labeled consistently. In the STG, where soma 
position is not a reliable indicator of cell identity, labeling was 
consistent in terms of the total number of responsive cells and 
their projections. 
Staining was absent in untreated nervous systems and in tissues 
that had been treated with IBMX alone (Fig. 5D,F). Treatment 
with 10 mM SNP alone also did not produce intense cGMP 
immunoreactivity, although in some instances cell bodies stained 
faintly in the STG (Fig. 5E). This is consistent with RIA studies 
that demonstrate that whereas IBMX has a relatively small effect 
on cGMP levels, it is greatly potentiated with the addition of NO 
(Fig. 2). The small effect of IBMX observed in the RIA studies is 
apparently below the detection threshold of the antibody used in 
our immunocytochemical procedures. The IBMX-dependent po- 
tentiation observed in both RIA and immunocytochemical studies 
implies that phosphodiesterase activity is high in these tissues and 
suggests that cGMP metabolism may be strictly regulated. 
Preabsorbing the anti-cGMP primary antiserum with 1O-5 PM 
cGMP eliminated cGMP immunoreactivity, whereas preabsorb- 
ing with lop5 PM CAMP and 10m5 PM GMP had no effect (data 
not shown). This is consistent with the specificity observed in 
previous reports (De Vente et al., 1987; Ewer et al., 1994). No 
cGMP immunoreactivity was detected when the primary antibody 
was omitted. 
In every cell observed in this study, intracellular cGMP immu- 
noreactivity was distributed diffusely throughout the cytoplasm, 
with cell somata and axonal projections labeling equally. Transec- 
tion of all attached nerves before exposure to NO, causing isola- 
tion of individual ganglia, had no effect on staining. Further, axons 
in nerves that had been isolated by transection continued to 
respond to NO, suggesting that NO is acting on targets located 
throughout the entirety of the cell, either in the cytoplasm or 
associated with the membrane. 
Among STNS ganglia, the STG contained the greatest propor- 
tion of NO-sensitive neurons, with nearly half of all cells (a 
subpopulation of -13 neurons) consistently responding to each 
NO donor (Fig. 5A-C). The somata of immunopositive neurons 
were intermixed with somata of nonresponding cells. Staining 
intensity varied among the responding cells, presumably reflecting 
a greater production of cGMP in some cells compared with their 
neighbors. Varied staining intensity is probably not a result of 
differential antibody penetration for the following reasons: (1) 
cells of equivalent thickness and depth in the ganglion ranged in 
staining intensity, and (2) labeling was often most intense in the 
core of the neuropil. In many cases, labeled processes could be 
followed from their point of exit in the neuropil to foregut muscle 
targets. Because soma position is not a reliable indicator of cell 
identity in the STG, individual motor neurons were tentatively 
identified by tracing axons to their peripheral targets. For exam- 
ple, Figure 6E shows the avn, which consistently contained four 
labeled axons; these most likely originate from four GM cells in 
the gastric CPG circuit. 
A single neuron showed cGMP immunoreactivity in the OG 
after NO treatment (Fig. 6B), although this cell often labeled 
weakly. This cell extended axons into both inferior oesophageal 
nerves (ions). Several neurons in the CGs labeled consistently 
(Fig. 6A). The most prominent was a large neuron with an 
elongate soma (60-70 pm wide, 100-150 pm long) positioned at 
the apex of the CG. This cell sent a large axon toward the 
suboesophageal ganglion via the circumoesophageal connectives, 
and is probably the homolog of the giant neuron that is immuno- 
reactive for proctolin and dopamine in lobster (Siwicki et al., 
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Figure 5. NO-responsive neurons in the STG. Patterns of 
cGMP immunoreactivity obtained after treatments with 
(A) 1 mM SNAP and 0.5 mM IBMX, (B) 10 mM SNP and 
0.5 IIIM IBMX, (C) 1 mM SIN-l and 0.5 mM IBMX, (0) 0.5 
mM IBMX alone, (E) 10 mM SNP alone, or (F) untreated. 
Note that soma position is variable, and thus is not a 
reliable indicator of cell identity in A-C. 
1987). Two or three additional large cells in the CG, as well as a 
cluster (S-8) of intermediate-sized neurons and many smaller 
cells, were consistently immunopositive for cGMP after NO 
treatment. 
Among anterior nerves the sons (Fig. 60), ions (Fig. 6B), uvns 
(Fig. 6E), and stn (Fig. 6C) contained labeled axons; no staining 
was observed in the ivn. In posterior nerves, cGMP immunoreac- 
tivity was usually confined to the dvn, dgn, dlvn, vlvn, andpdn. No 
staining was observed in the mvn. Finally, NO donors activated 
cGMP synthesis in the gastropyloric receptor cells (Fig. 6C), 
which reside in the vlvn (Katz and Harris-Warrick, 1990). 
Surprisingly, we did not observe cGMP-immunopositive cells 
after treatment with sinus gland extract and IBMX, despite our 
observation that this treatment produces a 30-fold increase in 
cGMP levels as measured by RIA (Fig. 3). We cannot explain this 
discrepancy, but we suggest hat one of the following possibilities 
may apply. First, subcellular pools of cGMP are differentially 
susceptible to fixation with paraformaldehyde (de Vente et al., 
1987) and it is possible that the membrane and cytosolic guany- 
late cyclases in the STNS are mobilizing distinct pools of cGMP. 
Consequently, cGMP produced by a membrane cyclase may be 
lost via diffusion or elution as the tissue was prepared for whole- 
mount ICC. Second, the antibody used for whole-mount ICC is 
less sensitive than the antibody used for RIA (e.g., although RIA 
measurements detected a fourfold increase in cGMP levels with 
IBMX treatment alone, this was not detected immunocytochem- 
100 firn 
ically). It is possible that peptide treatments induced a small 
(subthreshold for immunocytochemical detection) cGMP in- 
crease distributed across many STNS cells (e.g., neurons, glia, and 
sheath cells), whereas NO treatments induced a comparatively 
large (and thus detectable) cGMP increase in a small subset of 
neurons. 
Tissue distribution of NO- and peptide-activated cGMP 
Previous studies have indicated that the actions of CHH and 
related peptides are broad-based, elevating cGMP levels in many 
types of tissues. In lobster, CHHs stimulate cGMP synthesis in leg 
muscle, hepatopancreas, heart, testis, supraoesophageal ganglion, 
and ventral nerve cord, among others (Goy et al., 1987). In 
contrast, the distribution of an NO-sensitive cyclase is more re- 
stricted. For example, although lobster muscle contains a soluble 
cyclase, this enzyme does not respond to NO (Goy, 1990). 
We evaluated the stimulatory effects of NO and sinus gland 
extract (tested in the presence of IBMX and compared with 
control tissues treated with IBMX alone) on muscle, hepatopan- 
cress, SINS, and brain (Fig. 7). Only the STNS exhibited an 
increase in cGMP content in response to NO (Fig. 7B). Interest- 
ingly, applying IBMX alone caused a fivefold increase in cGMP 
levels in the brain, but had no effect on other, non-neuronal 
tissues (data not shown). An NO-signaling pathway has been 
identified in the crustacean brain (Johansson and Carlberg, 1994). 
It is possible that IBMX applications potentiated the effects of 
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Figure 6. NO-responsive neurons elsewhere in the STNS. A, Cell somata in the commissural ganglion. B, A single neuron in the oesophageal ganglion. 
C, The gastropyloric receptor cell in the vlvn. D, Axonal projections in the stn and sons. E, Four cGMP-immunopositive axons exiting the central neuropil 
of the STG. See Figure 1 for anatomical definitions. 
endogenously generated NO and that the level of endogenous NO 
is sufficient to saturate the system. 
As expected, the sinus gland extract was a potent activator of 
cGMP in all tissues surveyed (Fig. 7A). This probably reflects 
the broad control over cGMP metabolism by members of the 
hyperglycemic family of peptides (Sedlmeier and Keller, 1981; 
Goy, 1987). However, the sinus gland contains many other 
neuropeptides, and we cannot rule out possible effects of 
non-CHH peptides on cGMP production. Taken together, 
these results illustrate a sharp contrast between the global 
regulation of cGMP biosynthesis by peptides originating from 
the sinus gland, and the selective stimulation of cGMP in the 
nervous system by NO. 
DISCUSSION 
As a model system, the crustacean STNS has revealed a rich 
variety of ways by which synaptically delivered neurotransmitters 
can modulate the rhythmic motor output generated by dynamic 
circuits. Participatory roles for cyclic nucleotides in this process, 
however, are poorly understood. In this paper, we demonstrate 
two pathways for activating cGMP metabolism in the SINS that 
are mediated by distinct guanylate cyclases. Our findings raise the 
possibility that peptides in the CHH family or enzymes that 
generate NO may play a role in shaping motor output from the 
STNS. The observations presented above also provide a frame- 
work in which to study guanylate cyclase activation and the sub- 
sequent effects of cGMP on rhythmic motor output from CPGs. 
In this context, it is of obvious importance to consider possible 
biological sources and routes of delivery of CHH and NO to the 
STNS. The primary site of synthesis and release of CHH is the 
sinus gland (Dircksen et al., 1988; Keller et al., 1994), although 
small amounts have also been detected in pericardial organs 
(Keller et al., 1985). The sinus gland and the pericardial organs 
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Figure 7. Comparison of tissue responses to NO (A) and sinus gland 
extract (B). The effect of each agent in the presence of IBMX is compared 
with treatment with IBMX alone. *p < 0.05; ***p < 0.005 (Student’s t 
test). GA41 is a foregut muscle, and CF refers to muscles of the car frontale 
in the ophthalmic artery. Data are the mean ? SEM for four or more 
experiments, with the exception of experiments testing peptide extract 
effects on muscle and nervous tissue, which were performed in duplicate. 
are both well characterized neurohemal organs that release bio- 
active peptides and amines into the circulation. Released materi- 
als spread rapidly throughout the animal and can affect the 
physiological properties of targets as diverse as postural muscles 
(Livingstone et al., 1980), heart (Worden et al., 1995), and hepa- 
topancreas (Keller et al., 1985). It is feasible, therefore, that 
blood-borne CHH could regulate cGMP metabolism in the STNS. 
Interestingly, CHH differs from other sinus gland peptides in 
that it is lacking within the CNS and the STNS. For example, 
proctolin, red pigment concentrating hormone-like, and allatosta- 
tin-like peptides have been immunocytochemically mapped to the 
crab sinus gland (Christie et al., 1995); neurons immunopositive 
for these peptides also project directly to the STG, where they 
serve modulatory functions in STG circuits (Marder et al., 1986; 
Nusbaum and Marder, 1988; Skiebe and Schneider, 1994). Con- 
sequently, if members of the CHH peptide family are the active 
cGMP-stimulating component of the sinus gland extract, it is 
likely that they serve a general function in regulating cellular 
homeostasis that is common to many tissues rather than unique to 
the STNS (e.g., glycogen metabolism). 
With regard to an endogenous ource of NO, the situation is less 
clear. NOS generates NO. It is widely accepted that nicotinamide- 
adenine-dinucleotide phosphate (NADPH)-diaphorase histochemis- 
try (paraformaldehyde fixation) (Vincent and Kimura, 1992) is diag- 
nostic for the presence of neuronal NOS. When we applied this 
technique to the SINS and foregut musculature, we found no label- 
ing (data not shown). Perhaps NO originates from some other, 
non-neuronal tissue in the vicinity of the SINS. For example, dia- 
phorase staining or NOS activity in non-neuronal tissues has been 
reported in other arthropods (Radomski et al., 1991; Dow et al., 
1994; Miiller and Bicker, 1994). Interestingly, Radomski et al. (1991) 
have shown that Limulus hemocytes contain an NOS, suggesting that 
NO is generated in the arthropod hemolymph. In decapod crusta- 
ceans, the STG is positioned within the lumen of the ophthalmic 
artery, raising the possibility that STG neurons respond in viva to NO 
generated in the blood. Alternatively, the absence of NADPH- 
diaphorase labeling in the SINS may reflect an unusual sensitivity of 
the crustacean enzyme to paraformaldehyde fixation, as has been 
shown for the endothelial form of vertebrate NOS (Dinerman et al., 
1994). Finally, we must consider the possibility that the NO-sensitive 
guanylate cyclase that we have identified in the crab SINS is actually 
activated in viva by ligands other than NO (see Morton and Giunta, 
1992). 
Unlike the CHH peptides, which so far have been identified 
only in crustaceans (Keller, 1992) and perhaps in insects (Aud- 
sley et al., 1992), NO has been implicated in a wide variety of 
physiological functions across a diverse array of species. In 
vertebrates, NO is active in both neural and non-neural tissues, 
where it plays key roles in vascular, digestive, neuronal, and 
immune functions (Garthwaite and Boulton, 199.5; Konturek 
and Konturek, 1995; Umans and Levi, 1995). Accumulating 
evidence also supports a role for NO as a physiological regu- 
lator in invertebrate species. Among insects, NO-signaling 
pathways have been characterized in the CNS of the locust 
(Elphick et al., 1993, 1995; Mtiller and Bicker, 1994) in the 
salivary gland of the bloodsucking bug Rhodnius prolixus (Ri- 
beiro and Nussenzveig, 1993; Ribeiro et al., 1993), and in the 
Malpighian tubules of Drosophila (Dow et al., 1994). In mol- 
lusts, NOS-immunopositive neurons have been identified in the 
buccal ganglia of Lymnaea, and NO stimulates motor output 
from buccal CPGs (Moroz et al., 1993, 1994). In crustaceans, 
Johansson and Carlberg (1994) have biochemically demon- 
strated NOS activity and used NADPH-diaphorase histochem- 
istry to map the distribution of a NOS-like enzyme in the 
crayfish deutocerebrum, an observation recently confirmed by 
Talavera et al. (1995). Interestingly, NOS activity is promi- 
nently localized to olfactory centers in vertebrates (Breer and 
Shepherd, 1993) arthropods (Johansson and Carlberg, 1994; 
Muller and Bicker, 1994; Elphick et al., 1995) and molluscs 
(Gelperin, 1994) suggesting that certain functions of NO in the 
nervous system may be preserved across phyla (cf. Elphick et 
al., 1995). Taken together, these studies suggest that signaling 
pathways utilizing NO as an intercellular messenger have been 
evolutionarily conserved. Our data support this and suggest a 
possible role for NO as a neuronal messenger in the crustacean 
STNS. 
NO has been shown to control rhythmic activity in other neu- 
ronal networks. For example, NO increases the frequency of 
oscillation in Limax procerebral neurons (Gelperin, 1994) and 
dampens oscillations in networks of mammalian thalamocortical 
neurons (Pape and Mager, 1992). The diversity of substrates for 
cGMP, as well as the complex and dynamic aspects of STG 
circuitry, makes it difficult to predict an outcome of NO-activated 
cGMP synthesis in the STG. Additional work examining the 
effects of NO on both individual identified neurons, and on the 
production of patterned motor output from oscillating networks 
of cells, is required. In this regard, it is intriguing that only a 
subpopulation of neurons in the STG is sensitive to NO. Whether 
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cGMP is having a similar physiological effect in all NO-responsive 
cells is an important question that needs to be addressed. 
In summary, we have demonstrated that the crustacean SINS 
contains at least two distinct signaling pathways that stimulate cGMP 
metabolism. One pathway, activated by NO, is apparently restricted 
to the nervous system, whereas the other pathway, activated by sinus 
gland components (probably members of the CHH peptide family), 
is broadly distributed in many tissues. This work provides a starting 
point for physiological analyses of cGMP at the following levels of 
complexity: (1) in single, identifiable neurons within the gastric and 
pyloric networks in the STG, and (2) at the circuit level, where the 
effects of cGMP on patterned motor production can now be ex- 
plored. In addition, the experimentally accessible SINS offers a 
unique opportunity to compare the physiological roles of the cyto- 
plasmic isoform of guanylate cyclase (which can be activated by NO 
in a prominent subset of neurons) with the membrane isoform 
(which can be activated by CHH in an as yet unknown, but probably 
distinct, population of cells). 
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